This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Setting a high standard of cancer care for better patient benefits

Accuray
8 August, 2012  
The CyberKnife® Robotic Radiosurgery System is the only robot in the world capable of treating tumours anywhere in the body, regardless of their classification (common or rare, cancerous or non-cancerous) with sub-millimetre precision. Its image guidance technology can track in real time and automatically correct for any movements of the patient and the tumour during the treatment, enabling high doses of radiation to be delivered to the tumour while protecting healthy tissue.
During the CyberKnife stereotactic treatment, patients are comfortably bedded on the treatment table. No anaesthetic is required because the procedure is non-invasive and painless. Depending on the type of tumour to be treated, treatment usually takes between 30 and 90 minutes. A complete treatment course can be administered in one to five sessions. The CyberKnife System can be used on an outpatient basis with little or no convalescence and permits an immediate return to normal activity.
It is unique among all available radiotherapy systems in that its use typically extends a centre’s existing stereotactic program (brain metastasis, neuromas and meningiomas) from the traditional intracranial indications only to a full SBRT program (including primary and secondary spine, lung, liver and prostate lesions treated in five or less days), pushing the limits of currently available treatments in radiotherapy and providing a real alternative to invasive or costly procedures.
The TomoTherapy® System provides sophisticated and personalised intensity modulated radiation therapy (IMRT) treatments easily to a large patient population. Because 3D imaging is an integral part to treatment alignment, the TomoTherapy System provides precision and accuracy through daily image-guided radiation therapy. The binary collimator and the helical delivery provide optimal dose modulation; others are unable to achieve equivalent dose distributions in daily clinical practice. Finally, its integrated treatment planning and delivery solution provide easy quality assurance – the prerequisite for a safe patient treatment.
Complicated techniques such as simultaneous integrated boost treatments, extended longitudinal treatments and complex and concave dose patterns are now easy to plan and to deliver. The system provides a broad range of treatment options, from simple palliative to complex curative treatment goals, and is credited by physicians for its ease of use for every treatment indication and disease site.
With Accuray Exchange in Radiation Oncology (AERO), a global organisation for CyberKnife and TomoTherapy users, Accuray provides a dedicated platform for advancing patient care through worldwide clinical and technical collaboration. 
AERO’s mission is to provide a global forum for the clinical exchange of information between clinicians and physicists around the world for the purpose of setting a new standard in patient care and safety across treatments in the fields of SRS/SBRT, IMRT and conventional radiation therapy. 
“A global forum like AERO is critical as clinicians adopt and use new technologies to improve patient care and safety as well as develop new advances in radiation oncology.” said Professor Eric Lartigau, MD PhD, Head of Academic Radiotherapy, Centre Oscar Lambret, Lille, France, who is the global President of AERO.